Dr Jasjit Baveja is the Associate Director of Policy at the Medical Technology Association of Australia (MTAA), where she oversees regulatory affairs, clinical code of practice, procurement, industry policy, reimbursement, and advocacy. With over 20 years of experience in the medical device regulatory space, Dr Bavej’s expertise lies in providing educational opportunities for regulatory professionals in Australia to ensure continuous learning and professional development. She collaborates closely with the Therapeutic Goods Administration (TGA) to run workshops that provide invaluable experience, networking opportunities, and skill enhancement.
Regulations, such as the Therapeutic Goods Act of 1989, the Therapeutic Goods Regulations of 1990, and the Therapeutic Goods Medical Device Regulations of 2002, serve as a cornerstone for the medical technology industry and are essential in ensuring patient safety and promoting innovation within the industry.
According to Dr Baveja, “Setting stringent quality standards throughout the lifecycle of the medical device, regulations safeguard patient and public health by ensuring only safe and effective medical devices are on the market. With the confidence instilled in patients, healthcare workers, and broader stakeholders that any device that has gone through rigorous testing has met the scrutiny of regulatory requirements, the uptake of medical technology and novel medical devices is facilitated.”
MTAA offers workshops in medical device regulatory affairs for regulatory professionals, providing comprehensive education on Australian medical device regulations to enhance patient access to medical devices and streamline regulatory processes for faster approval times.
The Medical Technology Association of Australia (MTAA) is the national association representing companies in the medical technology industry.
MTAA represents manufacturers and suppliers of medical technology used in the diagnosis, prevention, treatment and management of disease and disability. The range of medical technology is diverse with products ranging from familiar items such as syringes and wound dressings, through to high-technology implanted devices such as pacemakers, defibrillators, hip and other orthopaedic implants. Products also include hospital and diagnostic imaging equipment such as ultrasounds and magnetic resonance imaging machines.
-
Report: Youth pathways to health services
The 2020 Youth Health Forum (YHF) was created to make young people’s ideas and experiences part of our national discussions about services for young Australians.
Healthcare professionals across Australia have long recognised the problem of young people falling through the gaps of a health system that wasn’t designed for them.
-
The world of AI avatars in dementia care
Dementia care is one of the critical issues facing the aged care industry. About 500,000 Australians currently live with the brain disorder condition, and this is tipped to rise to 1.1 million in a generation.
How to effectively provide quality care for people living with dementia was a key element of the royal commission into aged care, which found the complex care required was an ongoing challenge for the industry.
-
State of private healthcare in Australia
Australia’s healthcare system is often described as a mixed system, with a combination of public and private providers. While public healthcare through Medicare provides universal coverage for essential services, private healthcare offers additional options and amenities for those who can afford them.
Private Healthcare Australia (PHA) is the Australian private health insurance industry’s peak representative body that currently has 21registered health funds throughout Australia and collectively represents 98% of people covered by private health insurance. PHA member funds today provide healthcare benefits for over 14 million Australians.
